VICE HEALTH AND WELLNESS INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.005 CAD | -50.00% |
|
-.--% | -50.00% |
| 16/01 | Vice Health and Wellness Inc. Appoints Mr. Cody Corrubia as Corporate Secretary | CI |
| 16/01 | Vice Health and Wellness Inc. Appoints Mr. Cody Corrubia as CFO | CI |
Valuation
| Fiscal Period: September | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|
| Capitalization 1 | 21.63 | 1.521 | 2.25 | 1.342 |
| Enterprise Value (EV) 1 | 20.8 | 0.9437 | 1.571 | 1.321 |
| P/E ratio | -0.39 x | -0.34 x | -0.93 x | -0.7 x |
| Yield | - | - | - | - |
| Capitalization / Revenue | 3,02,71,49,410 x | 1,14,03,688 x | 4,75,75,170 x | 2,78,55,907 x |
| EV / Revenue | 2,91,19,55,541 x | 70,75,488 x | 3,32,11,151 x | 2,74,13,302 x |
| EV / EBITDA | -2.91 x | -0.48 x | -0.84 x | -0.86 x |
| EV / FCF | -1,54,29,581 x | -54,47,072 x | -46,84,710 x | -13,53,200 x |
| FCF Yield | -0% | -0% | -0% | -0% |
| Price to Book | 9.08 x | 1.26 x | 2.43 x | 5.37 x |
| Nbr of stocks (in thousands) | 3,527 | 4,630 | 8,157 | 12,383 |
| Reference price 2 | 6.131 | 0.3285 | 0.2759 | 0.1084 |
| Announcement Date | 28/01/20 | 28/01/21 | 28/01/22 | 27/01/23 |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: September | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Net sales | - | 0.007144 | 0.1334 | 0.0473 | 0.0482 |
| EBITDA 1 | -3.139 | -7.149 | -1.956 | -1.862 | -1.54 |
| EBIT 1 | -3.188 | -7.303 | -1.959 | -1.865 | -1.558 |
| Operating Margin | - | -1,02,219.02% | -1,468.84% | -3,944.17% | -3,233.76% |
| Earnings before Tax (EBT) 1 | -3.275 | -43.59 | -2.77 | -1.983 | -1.683 |
| Net income 1 | -6.735 | -44.05 | -3.383 | -1.983 | -1.683 |
| Net margin | - | -6,16,655.84% | -2,536.54% | -4,193.4% | -3,492.89% |
| EPS 2 | -6.157 | -15.61 | -0.9560 | -0.2971 | -0.1542 |
| Free Cash Flow | - | -1.348 | -0.1733 | -0.3353 | -0.9763 |
| FCF margin | - | -18,872.55% | -129.9% | -708.93% | -2,025.81% |
| FCF Conversion (EBITDA) | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - |
| Announcement Date | 28/01/19 | 28/01/20 | 28/01/21 | 28/01/22 | 27/01/23 |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: September | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - |
| Net Cash position 1 | 3.8 | 0.82 | 0.58 | 0.68 | 0.02 |
| Leverage (Debt/EBITDA) | - | - | - | - | - |
| Free Cash Flow | - | -1.35 | -0.17 | -0.34 | -0.98 |
| ROE (net income / shareholders' equity) | - | -835% | -139% | -209% | -349% |
| ROA (Net income/ Total Assets) | - | -76.1% | -56.2% | -115% | -170% |
| Assets 1 | - | 57.86 | 6.016 | 1.725 | 0.9911 |
| Book Value Per Share 2 | 6.560 | 0.6800 | 0.2600 | 0.1100 | 0.0200 |
| Cash Flow per Share 2 | 3.300 | 0.2300 | 0.1400 | 0.0900 | 0 |
| Capex 1 | 1.06 | 0.3 | 0.25 | - | - |
| Capex / Sales | - | 4,154.37% | 187.97% | - | - |
| Announcement Date | 28/01/19 | 28/01/20 | 28/01/21 | 28/01/22 | 27/01/23 |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -50.00% | 161K | |
| -.--% | 843M | |
| +10.24% | 684M | |
| +30.88% | 486M | |
| +38.09% | 262M | |
| 0.00% | 135M | |
| +126.09% | 64.29M |
- Stock Market
- Equities
- VICE Stock
- Financials Vice Health and Wellness Inc.